Peer-reviewedLicence not statedBritish Journal of Cancer
On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort
4 affiliations
- 1Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, China
- 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- 3Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China
- 4Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, China
Related
- A Causal Multi-modal AI Model Stratifies Residual Risk and Identifies Candidates for Treatment Escalation in Node-Positive HR+/HER2- Early Breast Cancer
- Stromal VEGF-C expression predicts nodal metastasis: implications for axillary surgery de-escalation in breast cancer
- National trends in dual de-escalation of axillary surgery and adjuvant radiation in early-stage HR+/HER2- breast cancer.
- De-escalation of axillary surgery in clinically node-negative (cN0) breast cancer: current evidence, advances, and controversies
- Risk Stratification and Surgical De-Escalation in T1 Invasive Lobular Carcinoma: A Retrospective Analysis of Preoperative Axillary Imaging
BibTeX
@article{xie2026ontreatment,
title = {{On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort}},
author = {Yifan Xie and Siyu Wu and Yan Huang and Ying Zhang and Miao Mo and Yajia Gu and Zhimin Shao and Guangyu Liu},
journal = {British Journal of Cancer},
year = {2026},
month = aug,
doi = {10.1038/s41416-026-03583-y},
url = {https://doi.org/10.1038/s41416-026-03583-y},
}
RIS
TY - JOUR
TI - On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort
AU - Yifan Xie
AU - Siyu Wu
AU - Yan Huang
AU - Ying Zhang
AU - Miao Mo
AU - Yajia Gu
AU - Zhimin Shao
AU - Guangyu Liu
PY - 2026
DA - 2026/08/27
JO - British Journal of Cancer
DO - 10.1038/s41416-026-03583-y
UR - https://doi.org/10.1038/s41416-026-03583-y
SN - 0007-0920
SN - 1532-1827
ER -